Literature DB >> 7083597

Investigation of urinary steroid profiles as a diagnostic method in Cushing's syndrome.

G Phillipou.   

Abstract

Patients with Cushing's syndrome may be discriminated from normal subjects on the basis of their respective neutral urinary steroid profile. In the former group, evidence is presented that lowered levels of T3 secondary to hypercortisolism, decrease the liver enzymes associated with 5 alpha-reductase and 11 beta-hydroxy steroid dehydrogenase activity. As a result the metabolism of cortisol and androstenedione in Cushing's syndrome yields a unique pattern dominated by 5 beta and 11 beta-hydroxy steroid metabolites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7083597     DOI: 10.1111/j.1365-2265.1982.tb02757.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  [Urinary steroid profile in Cushing syndrome and in tumors of the adrenal cortex].

Authors:  J Homoki; R Holl; W M Teller
Journal:  Klin Wochenschr       Date:  1987-08-03

2.  Adrenocortical carcinoma with Cushing's syndrome presenting unusual urinary 17-ketosteroid fractionation.

Authors:  H Watanobe; K Kannari; K Kimura; K Takebe
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

3.  Suspected Cushing's syndrome.

Authors:  K C McHardy
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-01

Review 4.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

5.  Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess.

Authors:  A Li; R Tedde; Z S Krozowski; A Pala; K X Li; C H Shackleton; F Mantero; M Palermo; P M Stewart
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

6.  Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women.

Authors:  A Stomby; K Simonyte; C Mellberg; M Ryberg; R H Stimson; C Larsson; B Lindahl; R Andrew; B R Walker; T Olsson
Journal:  Int J Obes (Lond)       Date:  2014-10-28       Impact factor: 5.095

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.